Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B-cell malignancies: Results of a phase I study
Hamlin, Paul A., Flinn, Ian W., Wagner-Johnston, Nina, Burger, Jan A., Coffey, Greg P., Conley, Pamela B., Michelson, Glenn, Leeds, Janet M., Der, Kenneth, Kim, Yvonne, Sabalvaro-Torres, Alice, BirrelLangue:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.25387
Date:
January, 2019
Fichier:
PDF, 1.01 MB
english, 2019
File converter
Plus de résultats de recherche
More benefits 
